1-9 of 9
Vijay G. Ramakrishnan, PhD
Close
Sort by
Journal Articles

Gene Expression Profiling of Kinetic Response to Proteasome Inhibitors in Innate and Acquired Resistant Multiple Myeloma

Amit Kumar Mitra, PhD, Vijay G. Ramakrishnan, PhD, Shaji K Kumar, MD, S. Vincent Rajkumar, MD, Brian G. Van Ness, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4405.
https://doi.org/10.1182/blood.V130.Suppl_1.4405.4405
Published: 2017
Journal Articles

Overcoming Resistance to Apoptosis in Multiple Myeloma By Simultaneous Inhibition of Bcl2 and IAP Families of Anti-Apoptotic Proteins

Marcus Gomez, Vijay G. Ramakrishnan, PhD, Vivek Prasad, Teresa K. Kimlinger, Utkarsh Painuly, MD, Lintao Bi, PhD, Vincent Rajkumar, MD, Shaji Kumar, MD
Journal: Blood
Blood (2014) 124 (21): 2088.
https://doi.org/10.1182/blood.V124.21.2088.2088
Published: 2014
Journal Articles

Simultaneous Inhibition of cIAP1, cIAP2 and XIAP Is Required for Inducing Apoptosis in Multiple Myeloma Cells.

Vijay G. Ramakrishnan, PhD, Teresa K. Kimlinger, Utkarsh Painuly, MD, Jessica Haug, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2012) 120 (21): 2943.
https://doi.org/10.1182/blood.V120.21.2943.2943
Published: 2012
Journal Articles

Preclinical Evaluation of AT219, a Small Molecule Inhibitor of MDM2 As an Anti-Myeloma Agent.

Vijay G. Ramakrishnan, PhD, Teresa K. Kimlinger, Timothy Halling, Jessica Haug, Utkarsh Painuly, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2012) 120 (21): 2948.
https://doi.org/10.1182/blood.V120.21.2948.2948
Published: 2012
Journal Articles

Promising Pre-Clinical Activity of A-1014907, a Dual Inhibitor of Aurora Kinases and VEGFR in Multiple Myeloma

Utkarsh Painuly, MD, Vijay G. Ramakrishnan, PhD, Teresa K. Kimlinger, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2012) 120 (21): 1848.
https://doi.org/10.1182/blood.V120.21.1848.1848
Published: 2012
Journal Articles

Pluripotent Stem Cell-Derived Human Natural Killer Cells with Potent Anti-Multiple Myeloma Activity,

David A. Knorr, BSc, Zhenya Ni, DVM/PhD, Allison Bock, Vijay G. Ramakrishnan, PhD, Shaji Kumar, MD, Dan S. Kaufman, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4034.
https://doi.org/10.1182/blood.V118.21.4034.4034
Published: 2011
Journal Articles

Mechanism of Action of a Novel c-Met Inhibitor MK2461 In Multiple Myeloma

Vijay G. Ramakrishnan, PhD, Teresa Kimlinger, Jessica Haug, Timothy Halling, Linda Wellik, S. Vincent Rajkumar, MD, Shaji Kumar, MD
Journal: Blood
Blood (2010) 116 (21): 4078.
https://doi.org/10.1182/blood.V116.21.4078.4078
Published: 2010
Journal Articles

Investigational Agent MLN2238/MLN9708, a Specific, Orally Available, Small Molecule Proteasome Inhibitor, Shows Promising In Vitro Activity Against Multiple Myeloma Cell Lines

Giada Bianchi, MD, Vijay G. Ramakrishnan, PhD, Teresa Kimlinger, Jessica Haug, S. Vincent Rajkumar, MD, Shaji Kumar, MD
Journal: Blood
Blood (2010) 116 (21): 3014.
https://doi.org/10.1182/blood.V116.21.3014.3014
Published: 2010
Journal Articles

Significant In Vitro Activity of a Novel Inhibitor of Apoptosis (IAP) Inhibitor LC161 In Multiple Myeloma

Jessica Haug, Vijay G. Ramakrishnan, PhD, Teresa Kimlinger, Timothy Halling, Linda Wellik, S. Vincent Rajkumar, MD, Shaji Kumar, MD
Journal: Blood
Blood (2010) 116 (21): 2998.
https://doi.org/10.1182/blood.V116.21.2998.2998
Published: 2010